Search

everythinglearnresearchcommunity

for

Search:↓

The combination therapy effectively treats infertility in PCOS without major side effects.

LH and hCG reduce certain protein levels in women's skin.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

Steroid cell tumors in ovaries are rare, can cause hormone changes, and may be cancerous.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

Deslorelin can help control reproduction and improve hair growth in German Spitz dogs.

The treatment slightly increased hair growth and was safe for most women.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Estrogen treatments can cause unwanted effects in men and should be used cautiously.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Recombinant gonadotropins improve future fertility in CHH patients.

A new compound that could treat various androgen-related conditions was created and analyzed.

Women with acne have lower levels of a specific hormone marker than women without acne.

New compounds may help treat prostate issues without affecting androgen receptors.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Serenoa repens may cause early puberty and should be used cautiously in children.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

A new treatment for hair loss shows promise with fewer side effects.